About: http://data.cimple.eu/news-article/2a766a827434a191a8a2e39270eb5c09043761c4ec8a23fc2f2ce8f8

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/2a766a827434a191a8a2e39270eb5c09043761c4ec8a23fc2f2ce8f8 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	If coronavirus vaccinations are rolled out widely, life could return to "normal" by next winter, one of the scientists behind the front-running coronavirus vaccine told British television on Sunday. Ugur Sahin, the Turkish co-founder of German firm BioN, told the BBC's The Andrew Marr Show that "this winter will be hard" without any major impact from vaccinations. Together with US giant Pfizer, BioN is developing the leading candidate in the worldwide chase for a vaccine, "If all goes well, we will start to deliver the vaccine at the end of this year, or beginning of next year," Sahin said. "Our goal is to deliver more than 300 million doses by April next year, which could already have an impact," he said. The infection rate will then go down in summer, he predicted, adding that it is essential that there is a high takeup of the vaccination by autumn. "I'm confident that this will happen, he said. A number of vaccination companies are working to increase the supply, he said: "so we could have a normal winter next (year)." Sahin and his wife Ozlem Tureci founded BioNTech in the western German city of Mainz in 2008. Having identified promising vaccine blueprints, the company formed a partnership in March with American pharmaceutical giant Pfizer. The announcement on Monday that their vaccine was more than 90 percent effective in trials led news bulletins around the world and sent stock markets and hopes soaring. BioNTech is now worth $25.8 billion (21.8 billion euros), more than Germany's largest lender Deutsche Bank. am/har
schema:headline	Vaccine scientist hopes for return to 'normal' by next winter
schema:mentions	Turkish people Deutsche Bank USA Gymnastics Pharmaceutical industry BBC News Germany City Pfizer United Kingdom Vaccine United States Severe acute respiratory syndrome coronavirus 2 The Andrew Marr Show The Infection Mainz
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-11-15 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	65 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software